Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases

Archives of Surgery

Volumn 145, Issue 4, 2010, Pages 340-345

  Glazer, Evan S ^a   Beaty, Karen ^a   Abdalla, Eddie K ^a   Vauthey, J Nicolas ^a   Curley, Steven A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINATE CALCIUM; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE CONTROL STUDY; COLORECTAL CANCER; COLORECTAL SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG MONITORING; ECHOGRAPHY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; SENSITIVITY AND SPECIFICITY; SYSTEMIC THERAPY; TREATMENT RESPONSE;

ADENOCARCINOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FALSE NEGATIVE REACTIONS; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77951449961     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2010.41     Document Type: Article

References (15)

1. Kemeny N. Presurgical chemotherapy in patients being considered for liver resection. Oncologist. 2007;12(7):825-839. (Pubitemid 47328226)
2. Takahashi S, Konishi M, Nakagohri T, Gotohda N, Saito N, Kinoshita T. Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis. Jpn J Clin Oncol. 2006;36(6):368-375. (Pubitemid 44043926)
3. Ribero D, Curley SA, Imamura H, et al. Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol. 2008;15(4):986-992.
4. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241(5):715-724. (Pubitemid 40604917)
5. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13(1):51-64. (Pubitemid 351206696)
6. Wiering B, Krabbe PF, Dekker HM, Oyen WJ, Ruers TJ. The role of FDG-PET in the selection of patients with colorectal liver metastases. Ann Surg Oncol. 2007; 14(2):771-779. (Pubitemid 46175326)
7. Takahashi S, Nagai K, Saito N, et al. Multiple resections for hepatic and pulmonary metastases of colorectal carcinoma. Jpn J Clin Oncol. 2007;37(3):186-192. (Pubitemid 47090693)
8. Koga R, Yamamoto J, Saiura A, Yamaguchi T, Hata E, Sakamoto M. Surgical resection of pulmonary metastases from colorectal cancer: four favourable prognostic factors. Jpn J Clin Oncol. 2006;36(10):643-648. (Pubitemid 44697558)
9. Bipat S, van Leeuwen MS, Comans EF, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology. 2005;237(1):123-131. (Pubitemid 41346155)
10. Dimitrakopoulou-Strauss A, Strauss LG, Schlag P, et al. Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma. J Nucl Med. 1998;39(7):1197-1202. (Pubitemid 28326150)
11. Tan MCB, Linehan DC, Hawkins WG, Siegel BA, Strasberg SM. Chemotherapyinduced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response. J Gastrointest Surg. 2007;11(9): 1112-1119.
12. Lejeune C, Bismuth MJ, Conroy T, et al. Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer. J Nucl Med. 2005;46(12):2020-2028. (Pubitemid 46657449)
13. Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol. 2006;24(24): 3939-3945. (Pubitemid 46630742)
14. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute; 2008.
15. Blazer DG III, Kishi Y, Maru DM, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008;26(33):5344-5351.